Difference between revisions of "Professional organizations"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "http://www.siog.org/" to "https://siog.org/") |
||
(12 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | If you notice an organization that is not included please let us know or add it yourself! | + | <span id="BackToTop"></span> |
+ | <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px; opacity:0.8; border-style: solid; border-color:DarkGray; border-width: 1px"> | ||
+ | [[#top|Back to Top]] | ||
+ | </div> | ||
+ | If you notice an organization that is not included please let us know or add it yourself! We have a separate page for [[Study Groups|study groups.]] | ||
{| class="wikitable sortable" <!--border="1" style="text-align:left;" !align="left" --> | {| class="wikitable sortable" <!--border="1" style="text-align:left;" !align="left" --> | ||
− | ! | + | !Association |
− | ! | + | !Acronym |
− | ! | + | !Target Audience |
|- | |- | ||
|[http://www.aonnonline.org/ Academy of Oncology Nurse & Patient Navigators] | |[http://www.aonnonline.org/ Academy of Oncology Nurse & Patient Navigators] | ||
Line 25: | Line 29: | ||
|AACR | |AACR | ||
|General Cancer | |General Cancer | ||
+ | |- | ||
+ | |[https://www.americanbrachytherapy.org/ American Brachytherapy Society] | ||
+ | |ABS | ||
+ | |Radiation Oncology | ||
|- | |- | ||
|[http://www.cancer.org/ American Cancer Society] | |[http://www.cancer.org/ American Cancer Society] | ||
Line 61: | Line 69: | ||
|AOA | |AOA | ||
|General Medicine | |General Medicine | ||
+ | |- | ||
+ | |[https://www.americanradiumsociety.org/ American Radium Society] | ||
+ | |ARS | ||
+ | |Radiation Oncology | ||
|- | |- | ||
|[https://www.astct.org/home American Society for Transplantation and Cellular Therapy] | |[https://www.astct.org/home American Society for Transplantation and Cellular Therapy] | ||
Line 78: | Line 90: | ||
|Surgical Oncology | |Surgical Oncology | ||
|- | |- | ||
− | |[ | + | |[https://www.asco.org American Society of Clinical Oncology] |
|ASCO | |ASCO | ||
|General Cancer | |General Cancer | ||
Line 125: | Line 137: | ||
|API | |API | ||
|Pathology | |Pathology | ||
+ | |- | ||
+ | |[https://www.astro.org/Affiliate/ARRO Association of Residents in Radiation Oncology] | ||
+ | |ARRO | ||
+ | |Radiation Oncology | ||
|- | |- | ||
|[http://bahno.org.uk/ British Association of Head & Neck Oncologists] | |[http://bahno.org.uk/ British Association of Head & Neck Oncologists] | ||
Line 201: | Line 217: | ||
|EBMT | |EBMT | ||
|Transplant-specific | |Transplant-specific | ||
+ | |- | ||
+ | |[https://www.esp-pathology.org/ European Society of Pathology] | ||
+ | |ESP | ||
+ | |Pathology | ||
|- | |- | ||
|[http://www.eusoma.org/ European Society of Breast Cancer Specialists] | |[http://www.eusoma.org/ European Society of Breast Cancer Specialists] | ||
Line 238: | Line 258: | ||
|Histology-specific | |Histology-specific | ||
|- | |- | ||
− | |[ | + | |[https://www.esmo.org/ European Society for Medical Oncology] |
|ESMO | |ESMO | ||
|General Cancer | |General Cancer | ||
Line 306: | Line 326: | ||
|Histology-specific | |Histology-specific | ||
|- | |- | ||
− | |[ | + | |[https://www.myeloma.org/ International Myeloma Foundation] |
− | | | + | |IMF |
|Histology-specific | |Histology-specific | ||
|- | |- | ||
Line 322: | Line 342: | ||
|Histology-specific | |Histology-specific | ||
|- | |- | ||
− | |[ | + | |[https://siog.org/ International Society of Geriatric Oncology] |
|SIOG | |SIOG | ||
|General Cancer | |General Cancer | ||
Line 328: | Line 348: | ||
|[http://www.irpa.net/page.asp?id=54507 International Society for Radiation Oncology] | |[http://www.irpa.net/page.asp?id=54507 International Society for Radiation Oncology] | ||
|ISRO | |ISRO | ||
+ | |Radiation Oncology | ||
+ | |- | ||
+ | |[https://isrsy.org/ International Society of Stereotactic Radiosurgery] | ||
+ | |ISRS | ||
|Radiation Oncology | |Radiation Oncology | ||
|- | |- | ||
Line 358: | Line 382: | ||
|Histology-specific | |Histology-specific | ||
|- | |- | ||
− | |[ | + | |[http://eng.ksmo.or.kr/main.html Korean Society of Medical Oncology] |
|KSMO | |KSMO | ||
|General cancer | |General cancer | ||
Line 382: | Line 406: | ||
|Hematology | |Hematology | ||
|- | |- | ||
− | |[ | + | |[https://www.cancer.gov/ National Cancer Institute] |
|NCI | |NCI | ||
|General Cancer | |General Cancer | ||
Line 453: | Line 477: | ||
|SITC | |SITC | ||
|Treatment-specific | |Treatment-specific | ||
+ | |- | ||
+ | |[https://integrativeonc.org/ Society for Integrative Oncology] | ||
+ | |SIO | ||
+ | |Supportive oncology | ||
|- | |- | ||
|[http://www.soc-neuro-onc.org/ Society for NeuroOncology] | |[http://www.soc-neuro-onc.org/ Society for NeuroOncology] |
Latest revision as of 17:31, 28 June 2024
If you notice an organization that is not included please let us know or add it yourself! We have a separate page for study groups.